These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The new serology of histocompatibility testing and its significance in human renal transplantation. Braun WE Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083 [No Abstract] [Full Text] [Related]
4. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization. Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465 [No Abstract] [Full Text] [Related]
5. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients. Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755 [No Abstract] [Full Text] [Related]
6. Why do HLA-nonidentical renal allografts survive 10 years or more? Thomas J; Thomas F; Lee HM Transplant Proc; 1977 Mar; 9(1):85-9. PubMed ID: 141140 [No Abstract] [Full Text] [Related]
7. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival. Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551 [No Abstract] [Full Text] [Related]
8. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation. Albrechtsen D; Arnesen E; Solheim BG; Thorsby E Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432 [No Abstract] [Full Text] [Related]
15. Recipient presensitization: a critical survey. Descamps B; Kreis H Adv Nephrol Necker Hosp; 1976; 6():443-61. PubMed ID: 828454 [No Abstract] [Full Text] [Related]
16. Considerations in immunologic monitoring of long-term transplant recipients. Thomas J; Thomas F; Johns C; Lee HM Transplant Proc; 1978 Sep; 10(3):569-72. PubMed ID: 152491 [No Abstract] [Full Text] [Related]
17. Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients. Farrow SS; Rossen RD; Suki WN; Hersh EM Proc Clin Dial Transplant Forum; 1973; 3():74-6. PubMed ID: 4283133 [No Abstract] [Full Text] [Related]
18. Immunologic tests for rejection. Gottlieb MN; Garovoy MR; Carpenter CB Urol Clin North Am; 1976 Oct; 3(3):553-73. PubMed ID: 136084 [No Abstract] [Full Text] [Related]
19. The relationship of the histocompatibility locus in the pig to allograft survival. White DJ; Bradley B; Calne RY; Binns RM Transplant Proc; 1973 Mar; 5(1):317-20. PubMed ID: 4266654 [No Abstract] [Full Text] [Related]
20. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]